Search Results 1651-1660 of 30436 for kidney disease

  1. Eribulin (intravenous route) - Side effects & uses - Mayo Clinic

    Heart rhythm problem (eg, congenital long QT syndrome)—Eribulin injection should not be given in patients with this condition. Kidney disease or; Liver disease— ...

  2. A Study to Evaluate the Role of NOX4 and Related Biomarkers in Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a devastating genetic disorder that causes numerous cysts in the kidneys, and remains a leading ...

  3. Strong-smelling Urine Not Necessarily Cause for Concern - Mayo Clinic News Network

    ... kidney infection and kidney damage. Diabetes: Strong sweet-smelling urine is ... Causes of chronic incontinence can involve prostate and bladder disorders, ...

  4. Moexipril and hydrochlorothiazide (oral route) - Side effects & dosage - Mayo Clinic

    This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure reduces the ...

  5. Carbidopa and levodopa (route not applicable) - Mayo Clinic

    However, elderly patients are more likely to have kidney problems, which may require caution in patients receiving this medicine. Breastfeeding. There are no ...

  6. Etoposide (oral route) - Side effects & dosage - Mayo Clinic

    However, elderly patients are more likely to have unwanted side effects (e.g., infection, nausea and vomiting, hair loss), and have age-related kidney problems, ...

  7. Albuterol (inhalation route) - Side effects & dosage - Mayo Clinic

    However, elderly patients are more likely to have age-related heart, kidney, or liver problems, which may require caution and an adjustment in the dose for ...

  8. Stress and high blood pressure: What's the connection? - Mayo Clinic

    However, short spikes in blood pressure can cause heart attacks or strokes and also may damage blood vessels, the heart, and the kidneys over time. The damage ...

  9. A Study of the Long-Term Safety, Tolerability, and Effectiveness of Tesevatinib for Patients Completing 24 Months of Treatment for Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    ... and effectiveness of tesevatinib for patients with autosomal dominant polycystic kidney disease, who started and completed 24 months of treatment for ...

  10. A Study To Assess Adverse Events And Effectiveness Of IntraVenous Infusions Of ABBV-CLS-628 In Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

    Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that causes fluid-filled cysts to develop in the kidneys ...